GXP in Research and Development

Improving both product and process understanding, in combination with quality risk management, will support the establishment of an appropriate control strategy for consistent product quality and improved process performance

GxP Compliance in R&D

The areas of Research and Development were in the past excluded from the “compliance infrastructure” traditionally applied to the GMP-compliant manufacturing and control operations.

However, the FDA’s ‘risk-based-approach’ initiative and, later, the guidelines that emerged from that initiative: ICH Q8, Q9, Q10, Process Analytical Technology (PAT)… brought the requirement for the application of GxP principles (GLP, GMP, GCP) to the entire Lifecycle of a pharmaceutical product in a much higher level.

Concepts such as Quality by Design (QbD) are applied since the initial stages of development. The application of solid scientific criteria for the evaluation of results and data or the design of experiments, contribute to the knowledge and understanding of the product and the process, which is the key for obtaining and demonstrating the necessary control on the process and its design and the consistent quality of the product.

Quality by Design

The manufacturing process, before its transfer to the production plant, it must be thoroughly understood, including the Critical Process Parameters (CPP). This knowledge provides the ability to make improvements within what is considered the Design Space without potentially affecting product quality. Consequently, an optimization of the process is achieved without the need for revalidation or regulatory approval.

During the development phases of drugs, products used in clinical trials must be manufactured with quality standards equivalent to those applied in commercial drugs, adapting some requirements to the development phases. The labelling and secondary packaging of clinical trial medication is an essential part of the process to ensure that volunteers or designated patients take assigned medication..

R&D Projects

Rephine has experience within the following GxP  related services associated within Research and Development:

  • Risk analysis during development, scaling and process validation
  • ICH Q8 development models
  • Preparation of GXP regulatory inspections (GLP, GMP, GCP)
  • Process Analytical Technology (PAT)
  • Development reports
  • Expert reports
  • GMP in Pharmaceutical Development
  • Support in labeling and distribution of medication for Clinical Trials
  • Internal audits in the Pharmaceutical Development areas
  • Review of Drug dossiers for Registration (DMF, CTD)
GxP Consultancy

Where do you Need our Help?

For GMP Auditing, Quality Assurance & Digitalisation, we’re the partner of choice for all the stakeholders we deal with.

We provide extensive GMP consulting services to help keep our clients ahead of the needs and expectations of regulators.

Browse Audit Library

GMP Audit Services

GxP Consultancy

GxP Consultancy

Global Audit Library

Global Audit Library



Related Resources

CE Mark MDSW Case Study Header Case Study

2023 Medical Devices CE Mark for a MDSW (Medical Device Software)

About this Case Study The case study involved CE Mark for a new Medical Device Software. The company has developed software that is considered as …

Read More
We're Exhibiting! India TUG (2000 × 1044px) (1) Article

Rephine Exhibit at India TrackWise User Group Mumbai – Sept 1st

Rephine to Exhibit at the Upcoming India TrackWise User Group in Mumbai on September 1st We’re thrilled to announce that the Rephine India team will …

Read More

Rephine Golden Ticket

With Rephine everyone’s a winner! Thank you for visiting us! Submit the form and take advantage of some sweet offers: 15% off library report*Or10% off …

Read More
TW China PR blog header Article

Rephine agrees Chinese distribution partnership with Trackwise

Rephine’s Chinese division signs to provide Implementation and Validation services for TrackWise EQMS solutions.   Stevenage, Hertfordshire, 4 August, 2023 – Rephine, the experts in …

Read More
Mock Inspection USA Case Study Header Case Study

2023 Mock Inspection USA Market

About this Case Study The case study involved a pharmaceutical company seeking to bring a product, manufactured in Europe, into the US market for commercialisation. …

Read More
Medical Devices service image.png Case Study

2023 Medical Devices Mock Inspection

About this Case Study The case study involved verifying GMP compliance in an IVD company to enable the commercialisation of their products in the USA. …

Read More
GG PR blog header (5) Article

Rephine and Greenlight Guru Partner to Enable QMS for the Medical Device Sector

Rephine now offering QMS services to medical device companies through new partnership. Stevenage, Hertfordshire, 28 July, 2023 – Rephine, the experts in quality assurance & …

Read More
IVD Tech file update Case Study Header Case Study

2023 In-Vitro Diagnostics Products Technical File Update

About this Case Study The case study involved updating the Technical File documentation for more than100 IVD products according to Regulation (EU) 2017/746. The company …

Read More
Rephine Symposium Blue Back General

Rephine Virtual Symposium 2023 Video Recordings

About these recordings Missed out on the insightful sessions and captivating discussions from our esteemed speakers at the Rephine Symposium? Don’t worry, we’ve got you …

Read More

Let's get in touch

Please get in touch. Our expert GMP audit team is only a click away, on standby to answer all your questions.
Social: Linkedin



  • Barcelona, Spain                               
  • +34 934 178065


  • Shanghai, China 


  • Hyderabad, India